secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xilio Therapeutics, Inc. (XLO)
CIK:        0001840233
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001558370-24-000383
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Xilio receives Nasdaq deficiency notice for bid price below $1.00/share
-----------------------------------------------------------------------

- Bid price closed below $1.00 for 30 consecutive business days; violates Minimum Bid Requirement.
- 180-day cure period expires July 17, 2024; must trade at $1.00+ for 10 consecutive days to regain compliance.
- May be eligible for extra 180-day period if transfer to Nasdaq Capital Market; no guarantee of success.
- Company will monitor bid price and evaluate options; potential delisting risk remains.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840233/000155837024000383/0001558370-24-000383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840233/000155837024000383/xlo-20240119x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer